Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone
Clinical trial NCT02305316 · COMPLETED
Trial details
- NCT number
- NCT02305316
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.